2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z

Magnetic resonance imaging-guided focused ultrasound unilateral pallidotomy for Parkinson’s disease: A report of 2 patients

H. Ito, T. Taira, S. Fukutake, K. Yamamoto, T. Yamaguchi, T. Kamei (Fujisawa, Japan)
Magnetic resonance-guided focused ultrasound unilateral thalamotomy for the treatment of essential tremor: Outcomes and complications after 1 year of follow-up in 21 patients

J. Máñez-Miró, L. Vela, F. Alonso-Frech, M. Di Leone, F. Hernández-Fernández, M. Del Álamo, J. Pineda-Pardo, R. Rodríguez-Rojas, E. de Luis-Pastor, R. Martínez-Fernández (Madrid, Spain)
Maintenance of safinamide 100 mg daily long-term

N. Foncea (Galdakao, Spain)
Malignant gliomas in patients with Huntington’s disease

S. Chandra, G. Suarez-Cedeno, E. Stimming (Houston, TX, USA)
Malignant neuroleptic syndrome following a sudden deep brain stimulation battery drain: Report of two cases

O. Yilmaz Kusbeci, A. Acarer, Y. Unsal, Z. Colakoglu, R. Bilgin (Izmir, Turkey)
Management of chronic polyneuropathy associated with levodopa-carbidopa intestinal gel infusion in Parkinson’s disease: Review of the strategies and perspectives

C. Cransac, J. Dupouy, P. Loubiere, B. Ackett, P. Cintas, C. Brefel Courbon, O. Rascol, F. ory Magne (Toulouse, France)
MANF improves the MPP+/MPTP-induced Parkinson’s disease via improvement of mitochondrial function and inhibition of oxidative stress

Y. Liu, J. zhang, Q. Cai, H. Sun, L. Jin (Shanghai, China)
Measuring salivary cortisol levels in persons with Parkinson’s disease (PD)

A. Hiller, B. Lobb, J. Proulx, J. Quinn (Portland, OR, USA)
Meta-Analysis of Short-afferent inhibition and Cognitive Impairment in Parkinson’s Disease

J.F. Martin-Rodriguez, P. Mir (Seville, Spain)
Metabolomic Profiling of Activated Microglial Cells

V. Vedam-Mai, T. Domenick, E. Gill, T. Garrett, R. Yost, M. Okun (Gainesville, FL, USA)
Methylphenidate in Progressive Supranuclear Palsy [PSP] – Old drug, New Indications?

N. Sawal, P. Bansal, R. Gupta (Chandigarh, India)
mGluR1 antibodies encephalitis: A rare cause of reversible ataxia and myoclonus syndrome

F. Ory Magne, C. Goillion, J. Dupouy, M. Simonetta, C. Brefel Courbon, O. Rascol, J. (Toulouse, France)
Microarray analysis upon an synthetic α-synuclein induced model reveals some susceptibility genes in Parkinson’s disease

E. Tao (Guangzhou, China)
Microbiota DNA in the blood of patients with Parkinson’s disease

S.Q. Xu, Y.W. Qian, X.D. Yang, S.D. Chen, Q. Xiao (Shanghai, China)
Microelectrode recording for optimization of the long-term outcome in subthalamic deep brain stimulation for Parkinson’s disease

A. Gamaleya, A. Tomskiy, A. Poddubskaya, S. Omarova, A. Dekopov, E. Salova, E. Bril, N. Fedorova (Moscow, Russian Federation)
Microglial activation, white matter and hippocampal damage correlate with cognitive impairment in chronic cerebral hypoperfused and MPTP-lesioned mice

Y. Gao, H. Tang, K. Nie, R. Zhu, L. Gao, S. Feng, L. Wang, J. Zhao, Z. Huang, Y. Zhang, L. Wang (Guangzhou, China)
MicroRNA expression misregulation in iPSC-derived dopaminergic neurons from sporadic and LRRK2-associated Parkinson disease patients

R. Fernández-Santiago, T. Botta-Orfila, X. Morató, C. Calatayud, R. Raquel, MJ. Martí, C. Gaig, A. Raya, A. Consiglio, E. Tolosa, M. Ezquerra (Barcelona, Spain)
MicroRNAs as Biomarkers for Parkinson’s Disease

S. Bissonnette, C. Thomas, A. Labadorf, R. James, M. Saint-Hilaire, R. Myers (Boston, MA, USA)
MicroRNAs Unveil Metabolic Imbalance in Spinocerebellar Ataxia Type-2

V. Swarup, R. Singh, H. Singh, I. Singh, M. Faruq, S. Vivekanandhan, A. Srivastava (New Delhi, India)
Microstructural Abnormalities in Drug-naïve Parkinson’s Disease with Mild Cognitive Impairment: A Diffusion Tensor Imaging Study

N. Li, L. Wang, X. Suo, Z. Lu, J. Li, J. Peng, Q. Gong, R. Peng (Chengdu, Sichuan Province, China)
Microstructural Changes in Normal Appearing White Matter in Parkinson’s Disease (PD) Correlate with Motor, Tremor, and Neuropsychiatric Scores

J. Kim, T. Baumeister, M. McKeown (Vancouver, BC, Canada)
Microstructural changes in white and grey matter related to apathy, depression and anxiety in de novo Parkinson’s disease patients

S. Prange, E. Metereau, A. Maillet, E. Lhommée, H. Klinger, P. Pelissier, D. Ibarrola, RA. Heckemann, E. Broussolle, A. Castrioto, L. Tremblay, V. Sgambato, P. Krack, S. Thobois (Bron, France)
Midbrain Diameter Measurements on High-Resolution Computer Tomography Scans to aid diagnosis of Progressive Supranuclear Palsy

S. Potluri, C. Gan, C. Thomas, B. Mohamed, S. Schwarz (Cardiff, United Kingdom)
Midbrain/pons area ratio and clinical features predict the prognosis of PSP

S. Cui, S. Chen (Shanghai, People’s Republic of China)
Mild Cognitive Impairment in Parkinson’s Disease Before and After Deep Brain Stimulation

A. Troster, A. Abbott, F. Ponce, H. Shill, S. Oravivattanakul, G. Moguel-Cobos, N. Salins, A. Lieberman, K. Hanson (Phoenix, AZ, USA)
Mild to moderate dyskinesia is not significantly related to the level of activity engagement or quality of life of patients with Parkinson’s disease

E. Goubault, S. Bogard, K. Lebel, C. Duval (Montréal, QC, Canada)
Mind and Movement in Parkinson’s disease: An experience with yoga

S. Varanese, N. Modugno (Pozzilli, Italy)
Mineralization pattern of the deep gray matter by susceptibility-weighted magnetic resonance imaging to differentiate Parkinsonian disorders

M. Modi, P. Singh (Chandigarh, India)
Mingo Supplement Trial: An Open-Labeled Randomized-Controlled Trial in X-linked Dystonia-Parkinsonism patients in the Province of Capiz, Philippines

P. Acuna, G. Solinap, M. Ang, J. de Guzman, C. Go (Charlestown, MA, USA)
Mirthful laughter avoided by directional stimulation in a Parkinson’s disease patient treated with deep brain stimulation

F. Alonso-Frech, M. Monge, C. Fernandez-Garcia, C. Villanueva (MADRID, Spain)
Missing Data in the Unified Dyskinesia Rating Scale (UDysRS)

S. Luo, X. Ren, W. Han, C. Goetz, G. Stebbins (Durham, NC, USA)
Mitochondrial morphometrics in idiopathic Parkinson‘s disease fibroblasts

P. Antony, O. Boyd, K. Mommaerts, K. Sokolowska, M. Ostaszewski, A. Baumuratov, L. Longhino, F. Poulain, R. Krueger, R. Balling, N. Diederich (Belvaux, Luxembourg)
Mitochondrial phenotype related to the A30P alpha-synuclein mutation as a patient-derived cellular model of Parkinson’s disease

B. Santos, P. Barbuti, P. Antony, J. Arias, A. Hummel, J. Schwamborn, R. Krüger (Belval, Luxembourg)
Models of Parkinson’s disease in vitro

A. Dilzoda (Tashkent, Uzbekistan)
Modified Frameless Stereotaxy for Gene Therapy in Pediatric Movement Disorder Patients

CH. Tai, SH. Tseng, RM. Wu, WL. Hwu (Taipei, Taiwan)
Modulation of CaMKIIa-NR2B interaction in levodopa-induced dyskinesia in 6-OHDA- lesioned Parkinson’s rats

XS. Wang, WW. Wang, CL. Xie (Wenzhou, China)
Molecular Genetics and Functional Studies of LRRK2 Gene Variations in Parkinson’s Disease

M-L. Chen, R-M. Wu (Taipei, Taiwan)
Molecular immunological action and epigenetic modification of the human papillomavirus vaccination and associated neuropsychiatric side effects

N. Kanzato, K. Nakachi, Y. Takahashi (Okinawa, Japan)
Molecular mechanisms of GCH1-associated Parkinson’s disease

J. Terbeek, W. Vandenberghe (Leuven, Belgium)
Molecular-genetic nature of Parkinson’s disease in the East European cohort

A. Ivashynka, S. Likhachev (Minsk, Belarus)
Mortality from Parkinson’s disease in China: Findings from a Ten-year follow up study in Shanghai

G. Wang, G. Xu, YQ. Zhang, SD. Chen (Shanghai, China)
Motivational effects on action selection and memory

S. Hirschbichler, J. Ibáñez, L. Rocchi, R. Greenwood, J. Rothwell, S. Manohar (London, United Kingdom)
Motivators, Barriers and Clinical Correlates of Physical Activity in Parkinson Disease

S. Mantri, S. Wood, J. Duda, J. Morley (Philadelphia, PA, USA)
Motor and cognitive deficits in a mouse model of tauopathy with tau isoforms imbalance: Potential therapeutic strategies

ME. Avale, SL. Espindola, A. Damianich, M. Sartor, J. Ferrario (Buenos Aires, Argentina)
Motor and cognitive progression in GBA-related PD patients submitted to Deep Brain Stimulation

L. Correia Guedes, C. Silva, R. Machado Bouça, N. Gonçalves, M. Fabbri, A. Castro Caldas, P. Pita Lobo, M.M. Rosa, B. Cattoni, H. Carvalho, A. Gonçalves Ferreira, J.J. Ferreira, M. Coelho (Lisbon, Portugal)
Motor and non-motor correlates of APOE-ε4 mediated cerebrospinal fluid concentrations of amino acids and monoamine metabolites in dementia with Lewy bodies compared with Alzheimer’s dementia and healthy controls

F. Oliveira, M. Miraldo, E. Castro-Neto, F. Machado, S. Almeida, S. Matas, P. Bertolucci, M. Naffah-Mazzacoratti (São Paulo, Brazil)
Motor and non-motor correlates of APOE-ε4 mediated cerebrospinal fluid concentrations of biomarkers of amyloidogenesis and neurodegeneration in dementia with Lewy bodies compared with Alzheimer’s dementia and healthy controls

F. Oliveira, M. Miraldo, E. Castro-Neto, F. Machado, S. Almeida, S. Matas, P. Bertolucci, M. Naffah-Mazzacoratti (São Paulo, Brazil)
Motor and Non-motor Features Predict Freezing of Gait in Parkinson’s Disease

N. D'Cruz, G. Vervoort, S. Fieuws, W. Vandenberghe, A. Nieuwboer (Leuven, Belgium)
Motor and Non-motor symptoms in Parkinson’s disease (PD): Which are more important?

G. Chan, N. Cheung, A. Leung, D. Chau, C.W. Woo, B. Chee, W.C. Fong (Hong Kong)
Motor and non-motor symptoms of a 7.5-year prospective study of patients with Parkinson’s disease

A. Yoritaka, Y. Shimo, T. Hatano, N. Hattori (Saitama, Japan)
Motor cortical excitability during voluntary inhibition of involuntary tic movements

C. Ganos, L. Rocchi, A. Latorre, L. Hockney, C. Palmer, E. Joyce, K. Bhatia, P. Haggard, J. Rothwell (Berlin, Germany)
Motor cortical inhibitory and facilitatory circuit interactions in Parkinson’s disease

J. Saravanamuttu, N. Radhu, K. Udupa, C. Gunraj, J. Baarbé, R. Chen (Toronto, ON, Canada)
Motor limitations are the most distressing alterations for people living with Parkinson’s disease?

C. Dias, M. d'Alencar, C. Ribas, M. Piemonte (São Paulo, Brazil)
Motor Performance and Quality of Life in a Community Exercise Program for Parkinson’s Disease

E. Stiles, K. Jaffe, B. Rossi, D. Riley (University Heights, OH, USA)
Motor speech and swallowing phenotype of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS)

A. Vogel, N. Rommel, A. Oettinger, L. Stoll, E-M. Kraus, C. Gagnon, P. Krumm, M. Horger, D. Timmann, E. Storey, L. Schöls, M. Synofzik (Melbourne, Australia)
Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Cerebrospinal Fluid C-Reactive Protein

H. Sanjari Moghaddam, M.H. Aarabi (Tehran, Islamic Republic of Iran)
Movement and postural control in focal dystonia subjects measured using surface electromyography

F. Chang, S. Babu, S. Kim, N. Mahant, O. Vucic, V. Fung (Wentworthville, Australia)
Movement disorder associated with 3-Idroxyisobutyryl-Coa hydrolase (HIBCH) deficiency

F. Nardecchia, L. Pollini, C. Carducci, M. Tolve, S. De Leo, C. Carducci, V. Leuzzi (Rome, Italy)
Movement disorder masquerading as seizure disorder

K. Ganesh (Madurai, India)
Movement disorders after stroke in the third Moroccan level hospital, Marrakech

A. Chahidi, M. Chraa, N. Kissani (Marrakech, Morocco)
Movement Disorders as Postinfectious Neurologic Syndromes

H. Mori (Kurashiki, Okayama, Japan)
Movement Disorders in Children with Autoimmune Diseases

D. Munoz, M. Troncoso, P. Santander, M. Hidalgo, R. Ruiz, V. Naranjo, P. Gonzalez, C. Elgueta, P. Parra, A. Hernandez, S. Lara, M. Franco, J. Zamora (Santiago, Chile)
Movement disorders in mitochondrial disease: Radio clinical correlation in pediatric patients

R. Zouari, M. Naifar, F. Kamoun, S. Ben Nsir, R. Ben Jemaa, W. Bouchaala, F. Ayadi, C. Triki (Sfax, Tunisia)
Movement Disorders Phenomenology in Focal Motor Seizures

A. Fasano, C. Di Bonaventura, F. Bove, A. Espay, F. Morgante, G. Fabbrini, R. Munhoz, D. Andrade, F. Borlot, F. Bui, G. Di Gennaro, R. Iorio, H. Katzberg, M. Luigetti, P. Striano, G. Defazio, A. Berardelli (Toronto, ON, Canada)
MRI and behavioural account of the aging cerebellum

M. Bares, P. Filip, C. Gallea, S. Lehericy, O. Lungu (Brno, Czech Republic)
MRI volumetrics in parkinsonian syndromes

K. Ma, A. Chan, L. Shi, J. Abrigo, T. Cheung, C. Lau, V. Mok (Hong Kong, Hong Kong)
MRI-guided Focused Ultrasound thalamotomy for Multiple Sclerosis-associated tremor: A case report

B. Fernández-Rodríguez, D. Urso, M. Monje, JA. Pineda-Pardo, M. del Álamo, R. Blazquez-Navarro, F. Hernández-Fernández, L. Vela, F. Alonso-Frech, R. Martínez-Fernández, J. Obeso (Móstoles, Spain)
MSA Preliminary Panamerican Report

M. Cesarini, E. Gatto, J. Etcheverry, G. Da Prat, N. Gonzalez Rojas, H. Teive, M. Rodriguez, J. Ziliani, M. Miranda, P. Chana, F. Cardoso, A. Cardozo, C. Uribe Roca, I. Amorin, L. Abaroa, c. Cosentino, Y. Nuñez, A. Lescano, E. Dieguez, A. Alleva, I. Litvan, G. Wenning (La Plata, Argentina)
Multi-echo GRE and DTI MR imaging of the Substantia Nigra in early Parkinson’s disease: A pilot 1-year prospective controlled study

T. Mestre, G. Melkus, G. Santos, D. Grimes, S. Chakraborty (Ottawa, ON, Canada)
Multi-limb dual-task cost in Parkinson disease: Evaluating effects of implicit and explicit cues

T. McIsaac, R. Cohen, R. Bay, J. Gupta, C. Adler (Mesa, AZ, USA)
Multi-modal retention in a phase III clinical trial in early Parkinson disease (STEADY-PD III)

B. Greco, R. Holloway, K. Hodgeman, S. Henderson, C. Tarolli, K. Biglan, T. Simuni (Rochester, NY, USA)
Multi-tiered Diagnostic Approaches Reveal a High Degree of Genetic Heterogeneity for Hereditary Cerebellar Ataxias: A Retrospective Review of an Australian Cohort

C. Kang, C. Liang, K. Ahmad, Y. Gu, SF. Siow, J. Colebatch, S. Whyte, K. Ng, P. Cremer, R. Davis, T. Roscioli, M. Cowley, J.S. Park, C. Sue, K. Kumar (Sydney, Australia)
Multimodal evoked potential analysis in Woodhouse-Sakati Syndrome

A.H. Abusrair, I. AlHamoud, S. Bohlega (Riyadh, Saudi Arabia)
Multimodal MRI markers modifications in multiple system atrophy: A longitudinal study

P. Péran, WG. Meissner, O. Rascol, A. Pavy-Le Traon (Toulouse, France)
Multimorbidity predicts quality of life but not motor severity in early Parkinson’s disease

R. Gravell, G. Duncan, T. Khoo, D. Burn, A. Sayer, R. Barker, R. Lawson, A. Yarnall (Newcastle upon Tyne, United Kingdom)
Multiple single unit activity in ventral intermediate thalamus of essential tremor patients during intention tremor

F. Windels, A. Giorni, T. Coyne, P. Silburn, P. Sah (Saint Lucia, Australia)
Multisite Tissue and Biofluid Sampling for Alpha-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)

L. Chahine, T. Beach, C. Coffey, C. Caspell-Garcia, C. Alder, G. Serrano, S. Mosovsky, T. Foroud, C. Linder, H. Riss, D. Ecklund, J. Seibyl, A. Mallya, V. Arnedo, L. Riley, K. Dave, D. Jennings, B. Mollenhauer (Pittsburgh, PA, USA)
Muscle Ultrasound Comparison Between Early And Intermediate Onset Friedreich’s Ataxia

R. Verbeek, A. Waalkens, M. Kuiper, C. Verschuuren-Bemelmans, J. vd Hoeven, J. de Vries, J. van Gaalen, M. Willemsen, H. Kremer, D. Sival (Groningen, Netherlands)
Musical sonification for the rehabilitation of Parkinsonian dysgraphia: behavioural validation

L. Véron-Delor, S. Pinto, A. Eusebio, J.L. Velay, J. Danna (Aix-en-Provence, France)
Myoclonus in the pediatric age group: A retrospective analysis of clinical and electrophysiological characteristics of patients referred to an electrophysiology laboratory

A. Gunduz, H. Yılmaz, V. Demirbilek, C. Yalçınkaya, N. Yeni, S. Saltık, M. E. Kızıltan (Istanbul, Turkey)

Jump to: View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z